Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemamali Samaratunga

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Analytical and Quantitative Cytology and Histology|September 9, 2008
Ductal adenocarcinoma of the prostate: current opinion and controversiesHemamali Samaratunga, Brett Delahunt
Pathology|April 23, 2008
Cellular angiofibroma of the scrotumHemamali Samaratunga, Peter Fitzpatrick
Pathology|September 22, 2007
Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polypHemamali Samaratunga, Bernadette Letizia
Pathology|July 11, 2012
Recently described and unusual variants of urothelial carcinoma of the urinary bladderHemamali Samaratunga, Brett Delahunt
Seminars in Diagnostic Pathology|March 17, 2015
Mesenchymal tumors of adult kidneyHemamali Samaratunga, Brett Delahunt
Pathology|May 5, 2010
Genitourinary pathology in the new millenniumHemamali Samaratunga, Jonathan I Epstein
World Journal of Urology|April 15, 2008
What is the molecular pathology of low-risk prostate cancer?Hemamali Samaratunga, Jonathan I Epstein
International Journal of Urology : Official Journal of the Japanese Urological Association|February 19, 2017
Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer RotterdamLars Egevad, Hemamali Samaratunga, Brett Delahunt
Pathology|September 28, 2017
The decline of medical publishing: the rise of the pseudo-journalBrett Delahunt, Hemamali Samaratunga, Lars Egevad
European Urology|February 22, 2021
Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Should Chromophobe Renal Cell Carcinoma Be Graded?Brett Delahunt, Hemamali Samaratunga, Lars Egevad
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Analytical and Quantitative Cytology and Histology|September 9, 2008
Ductal adenocarcinoma of the prostate: current opinion and controversiesHemamali Samaratunga, Brett Delahunt
Pathology|April 23, 2008
Cellular angiofibroma of the scrotumHemamali Samaratunga, Peter Fitzpatrick
Pathology|September 22, 2007
Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polypHemamali Samaratunga, Bernadette Letizia
Pathology|July 11, 2012
Recently described and unusual variants of urothelial carcinoma of the urinary bladderHemamali Samaratunga, Brett Delahunt
Seminars in Diagnostic Pathology|March 17, 2015
Mesenchymal tumors of adult kidneyHemamali Samaratunga, Brett Delahunt
Pathology|May 5, 2010
Genitourinary pathology in the new millenniumHemamali Samaratunga, Jonathan I Epstein
World Journal of Urology|April 15, 2008
What is the molecular pathology of low-risk prostate cancer?Hemamali Samaratunga, Jonathan I Epstein
International Journal of Urology : Official Journal of the Japanese Urological Association|February 19, 2017
Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer RotterdamLars Egevad, Hemamali Samaratunga, Brett Delahunt
Pathology|September 28, 2017
The decline of medical publishing: the rise of the pseudo-journalBrett Delahunt, Hemamali Samaratunga, Lars Egevad
European Urology|February 22, 2021
Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Should Chromophobe Renal Cell Carcinoma Be Graded?Brett Delahunt, Hemamali Samaratunga, Lars Egevad
Pageof 19